IRIS
BIANCHI, GIOVANNA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 21.760
AS - Asia 77
SA - Sud America 9
NA - Nord America 2
Totale 21.848
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 21.760
CN - Cina 62
SG - Singapore 9
BR - Brasile 8
VN - Vietnam 5
EC - Ecuador 1
HK - Hong Kong 1
MX - Messico 1
US - Stati Uniti d'America 1
Totale 21.848
Salva come PNG Salva come JPEG
Città #
Genova 13.268
Genoa 5.213
Rapallo 1.944
Vado Ligure 1.297
Bordighera 38
Beijing 27
Ho Chi Minh City 3
Singapore 2
São Paulo 2
Aurora 1
Benito Juarez 1
Caxias do Sul 1
Guayaquil 1
Haiphong 1
Hanoi 1
Hong Kong 1
Itumbiara 1
Nashville 1
Porto Alegre 1
Santa Luzia 1
São Vicente 1
Zhengzhou 1
Totale 21.807
Salva come PNG Salva come JPEG
Nome #
Implementation of the Frailty Index in hospitalized older patients: Results from the REPOSI register 259
Prognostic value of degree and types of anaemia on clinical outcomes for hospitalised older patients 231
Heterogeneity and frequency of BRAF mutations in primary melanoma: Comparison between molecular methods and immunohistochemistry 214
A combination of immunohistochemistry and molecular approaches improves highly sensitive detection of BRAF mutations in papillary thyroid cancer 194
Pathway-based analysis of a melanoma genome-wide association study: analysis of genes related to tumour-immunosuppression. 189
An upstream positive regulatory element in human GM-CSF promoter is recognized by NF-kB/Rel family members 184
Incidence of other neoplasia in Italian melanoma-prone families with p16 (GLy93Trp) mutation 177
Granulocyte-macrophage colony-stimulating factor activity in cerebrospinal fluid 177
Contribution of germline mutations in the BRCA and PALB2 genes to pancreatic cancer in Italy. 177
CDKN2A is the main susceptibility gene in Italian pancreatic cancer families. 177
H and L ferritin gene expression in U937 cells induced to macrophagedifferentiation 172
Association of MC1R Variants and Host Phenotypes With Melanoma Risk in CDKN2A Mutation Carriers: A GenoMEL Study 169
Genome-wide association study identifies novel loci predisposing to cutaneous melanoma. 168
Germline MLH1 and MSH2 mutations in Italian pancreatic cancer patients with suspected Lynch syndrome. 167
CDKN2A and MC1R analysis in amelanotic and pigmented melanoma. 166
c-Rel and p65 subunits bind to an upstream NF-kB site in human granulocyte macrophage-colony stimulating factor promoter involved in phorbol ester response in 5637 cells 164
Functional analysis of CDKN2A/p16INK4a 5'-UTR variants predisposing to melanoma 163
Association of Genetic Variants in CDK6 and XRCC1 with the Risk of Dysplastic Nevi in Melanoma-Prone Families. 160
Cytokine expression in human primary and metastatic melanoma cells: analysis in fresh bioptic specimens 159
A flexible multiplex bead-based assay for detecting germline CDKN2A and CDK4 variants in melanoma-prone kindreds 158
Brooke-Spiegler syndrome tumor spectrum beyond the skin: a patient carrying germline R936X CYLD mutation and a somatic CYLDmutation in Brenner tumor 158
Early onset may predict G101W CDKN2A founder mutation carrier status in Ligurian melanoma patients. 157
A single genetic origin for the G101W CDKN2A mutation in 20 melanoma-prone-families 157
CDKN2A and CDK4 mutation analysis in Italian melanoma-prone families: functional characterization of a novel CDKN2A germ line mutation 156
Functional characterization of a multi-cancer risk locus on chr5p15.33 reveals regulation of TERT by ZNF148 156
Increased Risk of Colorectal Adenomas in Italian Subjects Carrying the p53 PIN3 A2-Pro72 Haplotype. 155
A comparison of CDKN2A mutation detection within the Melanoma Genetics Consortium (GenoMEL) 154
Discovery of a novel glucose metabolism in cancer: The role of endoplasmic reticulum beyond glycolysis and pentose phosphate shunt 153
Familial Melanoma and Pancreatic Cancer 151
A case of chronic myelogenous leukemia with unusual chromosomal abnormality. 151
Gly101Trp germline mutation in the CDKN2A gene in familial and non familial Ligurian melanoma patients 149
Features associated with germline CDKN2A mutations: A GenoMEL study of melanoma-prone families from three continents 144
Molecular characterization of an Italian series of sporadic GISTs. 144
Novel PTCH1 Mutations in Patients with Keratocystic Odontogenic Tumors Screened for Nevoid Basal Cell Carcinoma (NBCC) Syndrome 144
Clinical genetic testing for familial melanoma in Italy: a cooperative study. 141
Nevoid Basal Cell Carcinoma Syndrome in infants: improving diagnosis. 140
ANALISI GENOME-WIDE PER LA SUSCETTIBILITÀ AL MELANOMA: NUOVI LOCICHE CONFERMANO IL RUOLO DEI GENI DELLA PIGMENTAZIONE 140
Genome-wide association study identifies three new melanoma susceptibility loci 140
An upstream negative regulatory element in human granulocyte-macrophage colony-stimulating factor promoter is recognised by AP1 family members 139
Genetic testing for melanoma 136
Intercellular adhesion molecule-1 (ICAM-1) and granulocyte-macrophage colony stimulating factor (GM-CSF) co-expression in cutaneous malignant melanoma lesions. 136
Prevalence of the E318K MITF germline mutation in Italian melanoma patients: associations with histological subtypes and family cancer history. 136
A variant in FTO shows association with melanoma risk not due to BMI. 136
Genome-wide association study identifies a new melanoma susceptibility locus at 1q21.3 136
Effect of primaquine on erythrocytes with NADH-methaemoglobin reductase deficiency and low glutathione reductase activity. 133
Coexisting NRAS and BRAF Mutations in Primary Familial Melanomas with Specific CDKN2A Germline Alterations. 133
Genome-wide meta-analysis identifies five new susceptibility loci for cutaneous malignant melanoma 133
Role of the EGF +61A>G polymorphism in melanoma pathogenesis: an experience on a large series of Italian cases and controls. 132
High-risk melanoma susceptibility genes and pancreatic cancer, neural system tumors, and uveal melanoma across GenoMEL 131
Impact of E27X, a novel CDKN2A germ line mutation, on p16 and p14ARF expression in Italian melanoma families displaying pancreatic cancer and neuroblastoma. 131
What is new in melanoma research: genetics and epidemiology of melanoma in 2003? Review of a workshop held in Milan in May 2003 129
Patched homolog 1 gene mutation (p.G1093R) induces nevoid basal cell carcinoma syndrome and non-syndromic keratocystic odontogenic tumors: A case report. 129
Fine mapping of genetic susceptibility loci for melanoma reveals a mixture of single variant and multiple variant regions. 129
Electrophoretic pattern of NADPH - dependent oxidoreductive activities in the K562 and HL60 leukemic cell lines 128
Lactoferrin as a possible transcriptional regulator 128
Varianti polimorfiche del gene MC1R (Melanocortin receptor 1) nella popolazione ligure ed associazione con il rischio di melanoma 127
The 5'-untranslated region of p16INK4a melanoma tumor suppressor acts as a cellular IRES, controlling mRNA translation under hypoxia through YBX1 binding 127
Somatic BRAF and NRAS Mutations in Familial Melanomas with Known Germline CDKN2A Status: A GenoMEL Study. 127
On the Xq13 breakpoint: clinical and cytogenetic observations in a patient with acute myelogenous leukemia. 126
Analysis of p16 protein expression in familial melanoma patients: correlation with germline status. 126
Genomic rearrangements of the CDKN2A locus are infrequent in Italian malignant melanoma families without evidence of CDKN2A/CDK4 point mutations 126
Absence of high risk gene mutations in hereditary melanoma points to the interplay between somatic and low risk germline variants 126
Cell-type–specific eQTL of primary melanocytes facilitates identification of melanoma susceptibility genes 126
BRAF gene is somatically mutated but does not make a major contribution to malignant melanoma susceptibility: the Italian Melanoma Intergroup Study 125
Unusual Ph translocations in CML: four new cases 125
Rare missense variants in POT1 predispose to familial cutaneous malignant melanoma 125
"Gestione Melanoma" un "database" relazionale per lo studio e l’approfondimento della relazione genotipo/fenotipo e genotipo/ambiente nel melanoma familiare e sporadico 124
Characterization of a triplex DNA-binding protein encoded by an alternative reading frame of loricrin 123
Urinary granulopoietic activity in chronic myelogenous leukemia: follow-up and correlation with various phases of the disease. 123
High prevalence of the G101W germline mutation in the CDKN2A (P16INK4A) gene in 62 Italian malignant melanoma families 123
High prevalence of the Gly101Trp germline mutation in the CDKN2A gene in 62 small Italian families 122
Mutation screening of the CDKN2A promoter melanoma families 122
Expression and genomic configuration of GM-CSF, IL-3, M-CSFreceptor (C-FMS), early growth response gene-1 (EGR-1) and M-CSF genes in primary myelodysplastic syndromes 122
Effect of endothelial cell conditioned medium on the growth of human bone marrow fibroblasts 122
A nuclear factor that Down-Modulates the Granulocyte-Macrophage Colony-Stimulating Factor Expression. 122
Linkage Analysis in melanoma prone families 121
MC1R variation and melanoma risk in relation to host/clinical and environmental factors in CDKN2A positive and negative melanoma patients. 121
The role of AIRE polymorphisms in melanoma. 121
Identification of a SUFU germline mutation in a family with Gorlin syndrome 120
Novel MC1R variants in Ligurian melanoma patients and controls 120
Hereditary trichilemmal cysts: A proposal for the assessment of diagnostic clinical criteria 120
CDKN2A mutations and MC1R variants in Italian patients with single or multiple primary melanoma 120
3’UTR polymorphisms in the CDKN2A gene and age at onset of familial and sporadic melanoma 119
CDKN2A germline mutation analysis in patients with pancreatic adenocarcinoma 118
CDKN2A Unclassified Variants in Familial Malignant Melanoma: Combining Functional and Computational Approaches for Their Assessment 118
Expression and localization of mutant p16 proteins in melanocytic lesions from familial melanoma patients 118
Italian Melanoma-prone Families:Germline mutational analysis and Clinical-Epidemiological Characterization 117
Karyotype evolution in a case of chronic myelogenous leukemia with an unusual Philadelphia chromosome translocation, t(4;22), and an additional translocation, t(3;5). 117
Duplication of CXC chemokine genes on chromosome 4q13 in a melanoma-prone family. 116
Sporadic Multiple Primary Melanoma Cases : CDKN2A Germline Mutations With A Founder Effect 115
CDKN2A germline mutation analysis in patients with pancreatic adenocarcinoma from Liguria 115
Masked Philadelphia chromosome caused by translocation (9;11;22) 115
Ink4/ARF germline mutations and additional neoplasia in pancretic cancer patients and their families 114
Absence of melanocortin 1 receptor variants in Ligurian G101W families 114
MDM2 SNP309 genotype influences survival of metastatic but not of localized neuroblastoma 114
3’UTR polymorphisms in the CDKN2A gene and age at onset of familial and sporadic melanoma from Liguria 114
Characterization of Ligurian Melanoma families and risk of occurence of other neoplasia 113
Lactoferrin binding sites and nuclear localization in K562(S) cells 113
Selection criteria for genetic assessment of patients with familial melanoma 112
Methemoglobin reductase variability as related to NAD glycohydrolase activity. 112
Totale 13.976
Salva come PNG Salva come JPEG
Categoria #
all - tutte 69.699
article - articoli 52.893
book - libri 0
conference - conferenze 15.178
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.628
Totale 139.398
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021811 0 0 0 72 60 92 60 102 118 106 94 107
2021/20222.199 46 191 149 296 103 129 158 526 71 204 76 250
2022/20232.387 273 152 16 215 478 420 14 139 372 15 249 44
2023/20241.163 60 147 16 120 87 221 69 59 95 27 60 202
2024/20253.575 130 262 130 248 363 386 436 632 185 123 276 404
2025/20261.463 686 130 245 402 0 0 0 0 0 0 0 0
Totale 22.029